|
US6972193B1
(en)
*
|
1993-02-12 |
2005-12-06 |
Board Of Trustees Of Leland Stanford Junior University |
Regulated transcription of targeted genes and other biological events
|
|
US6891021B2
(en)
*
|
1993-02-12 |
2005-05-10 |
Board Of Trustees Of The Leland Stanford Junior University |
Regulated apoptosis
|
|
CA2372198A1
(en)
*
|
1999-05-14 |
2000-11-23 |
Medical Research Council |
Protein scaffold and its use to multimerise monomeric polypeptides
|
|
AU4933200A
(en)
*
|
1999-05-14 |
2000-12-05 |
Medical Research Council |
Oligomeric chaperone proteins
|
|
WO2000071743A1
(fr)
*
|
1999-05-25 |
2000-11-30 |
Eisai Co., Ltd. |
Methode bihybride dans une cellule de mammifere
|
|
DE60040147D1
(de)
*
|
1999-05-28 |
2008-10-16 |
Targeted Genetics Corp |
Methoden und zusammensetzungen zur reduktion des tumor-nekrosis-faktor-spiegels (tnf) bei tnf-assoziierten erkrankungen
|
|
CA2369855A1
(en)
*
|
1999-05-28 |
2001-01-04 |
Sangamo Biosciences, Inc. |
Molecular switches
|
|
US7057015B1
(en)
|
1999-10-20 |
2006-06-06 |
The Salk Institute For Biological Studies |
Hormone receptor functional dimers and methods of their use
|
|
WO2001036623A2
(en)
*
|
1999-11-05 |
2001-05-25 |
Avigen, Inc. |
Ecdysone-inducible adeno-associated virus expression vectors
|
|
CA2398010A1
(en)
|
2000-01-24 |
2001-07-26 |
The Trustees Of Columbia University In The City Of New York |
An in vivo screen using chemical inducers of dimerization
|
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
|
JP5031967B2
(ja)
*
|
2000-03-22 |
2012-09-26 |
イントレキソン コーポレーション |
新規エクジソン受容体ベースの誘導性遺伝子発現系
|
|
WO2001098507A1
(en)
*
|
2000-06-16 |
2001-12-27 |
Ariad Gene Therapeutics, Inc. |
Chimeric hsf transcription factors
|
|
US7011972B2
(en)
|
2000-07-18 |
2006-03-14 |
The Scripps Research Institute |
Fusion polypeptide comprising two ligand binding domains
|
|
JP2004504029A
(ja)
*
|
2000-07-18 |
2004-02-12 |
ノバルティス アクチエンゲゼルシャフト |
単鎖、一量体、リガンド依存性ポリペプチドスイッチを用いる遺伝子発現の調節
|
|
WO2002008286A2
(en)
*
|
2000-07-21 |
2002-01-31 |
Syngenta Participations Ag |
Zinc finger domain recognition code and uses thereof
|
|
US8105825B2
(en)
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
|
US6576422B1
(en)
|
2000-10-17 |
2003-06-10 |
Rohm And Haas Company |
Method for identifying products employing gene expression
|
|
EP1373470B1
(en)
|
2001-02-20 |
2013-04-24 |
Intrexon Corporation |
Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
ES2424812T3
(es)
|
2001-02-20 |
2013-10-08 |
Intrexon Corporation |
Receptores X retinoides quiméricos y su uso en un sistema inducible de expresión génica basado en receptores de ecdisona novedoso
|
|
WO2002066613A2
(en)
|
2001-02-20 |
2002-08-29 |
Rheogene Holdings, Inc |
Novel ecdysone receptor/invertebrate retinoid x receptor-based inducible gene expression system
|
|
CA2438133C
(en)
|
2001-02-20 |
2015-01-27 |
Rheogene, Inc. |
Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
DE60239097D1
(de)
|
2001-03-02 |
2011-03-17 |
Gpc Biotech Ag |
Drei-hybrid-assaysystem
|
|
US20040224385A1
(en)
*
|
2001-08-20 |
2004-11-11 |
Barbas Carlos F |
Zinc finger binding domains for cnn
|
|
ATE360680T1
(de)
*
|
2001-08-23 |
2007-05-15 |
Univ California |
Universelles, durch licht einschaltbares genpromotorsystem
|
|
US20030064053A1
(en)
*
|
2001-08-31 |
2003-04-03 |
Shengjiang Liu |
Multivalent protein conjugate with multiple ligand-binding domains of receptors
|
|
WO2003027289A1
(en)
|
2001-09-26 |
2003-04-03 |
Rheo Gene Holdings, Inc. |
Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
|
|
CA2462598A1
(en)
*
|
2001-10-01 |
2003-04-10 |
Bioimage A/S |
A method of detecting intracellular protein-protein interactions using three heterologous conjugates
|
|
US8039243B2
(en)
*
|
2002-01-23 |
2011-10-18 |
Wisconsin Alumni Research Foundation |
Insertion sequence-free bacteria
|
|
US8765408B2
(en)
|
2002-01-23 |
2014-07-01 |
Wisconsin Alumni Research Foundation |
Prophage element-free bacteria
|
|
US20060270043A1
(en)
*
|
2002-01-23 |
2006-11-30 |
Blattner Frederick R |
Bacteria with reduced genome
|
|
US6989265B2
(en)
*
|
2002-01-23 |
2006-01-24 |
Wisconsin Alumni Research Foundation |
Bacteria with reduced genome
|
|
US8119365B2
(en)
*
|
2002-01-23 |
2012-02-21 |
Wisconsin Alumni Research Foundation |
Insertion sequence-free bacteria
|
|
JP4547911B2
(ja)
|
2002-02-01 |
2010-09-22 |
アリアド・ファーマシューティカルズ・インコーポレイテッド |
リン含有化合物およびその用途
|
|
US6845929B2
(en)
*
|
2002-03-22 |
2005-01-25 |
Ali Dolatabadi |
High efficiency nozzle for thermal spray of high quality, low oxide content coatings
|
|
US7083918B2
(en)
|
2002-04-24 |
2006-08-01 |
The Trustees Of Columbia University In The City Of New York |
Bacterial small-molecule three-hybrid system
|
|
CA2485939C
(en)
*
|
2002-05-29 |
2013-10-29 |
Regeneron Pharmaceuticals, Inc. |
Inducible eukaryotic expression system
|
|
US8673589B2
(en)
|
2002-05-29 |
2014-03-18 |
Regeneron Pharmaceuticals, Inc. |
Inducible eukaryotic expression system
|
|
US7303906B2
(en)
*
|
2002-09-06 |
2007-12-04 |
Wisconsin Alumni Research Foundation |
Competent bacteria
|
|
CA2503787A1
(en)
*
|
2002-11-05 |
2004-05-27 |
Regeneron Pharmaceuticals, Inc. |
Methods of isolation of active compounds and activated targets
|
|
US7385027B2
(en)
*
|
2003-01-07 |
2008-06-10 |
University Of Kentucky Research Foundation |
Membrane-permeable peptide capable of calpain inhibition
|
|
US7304161B2
(en)
|
2003-02-10 |
2007-12-04 |
Intrexon Corporation |
Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
|
|
US7456315B2
(en)
|
2003-02-28 |
2008-11-25 |
Intrexon Corporation |
Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
|
WO2005017149A1
(en)
|
2003-06-03 |
2005-02-24 |
Cell Genesys, Inc. |
Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
|
|
US20050136035A1
(en)
*
|
2003-06-03 |
2005-06-23 |
Derek Ko |
Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
|
|
US7935510B2
(en)
|
2004-04-30 |
2011-05-03 |
Intrexon Corporation |
Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
US7714119B2
(en)
*
|
2004-07-13 |
2010-05-11 |
Biosante Pharmaceuticals, Inc. |
AAV vector compositions and methods for enhanced expression of immunoglobulins using the same
|
|
US7632509B2
(en)
|
2005-07-19 |
2009-12-15 |
Biosante Pharmaceuticals, Inc. |
Methods to express recombinant proteins from lentiviral vectors
|
|
US20070292922A1
(en)
*
|
2006-03-31 |
2007-12-20 |
Cell Genesys, Inc. |
Regulated expression of recombinant proteins from adeno-associated viral vectors
|
|
KR101666228B1
(ko)
|
2007-09-28 |
2016-10-13 |
인트렉손 코포레이션 |
생물치료학적 분자를 발현시키기 위한 치료학적 유전자-스위치 작제물 및 생물반응기, 및 이의 용도
|
|
CA2794196A1
(en)
|
2010-03-23 |
2011-09-29 |
Intrexon Corporation |
Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof
|
|
US9315825B2
(en)
|
2010-03-29 |
2016-04-19 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
|
US20130023033A1
(en)
|
2010-03-29 |
2013-01-24 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
|
SG10201600912SA
(en)
|
2011-03-04 |
2016-03-30 |
Intrexon Corp |
Vectors conditionally expressing protein
|
|
EP2699688A1
(en)
|
2011-04-20 |
2014-02-26 |
The Trustees Of The University Of Pennsylvania |
Regimens and compositions for aav-mediated passive immunization of airborne pathogens
|
|
WO2014100913A1
(en)
*
|
2012-12-24 |
2014-07-03 |
Beijing Anxinhuaide Biotech. Co., Ltd |
Improving the half life of a therapeutic polypeptide by fusing with a trimeric scaffold protein via a spacer
|
|
ES2683329T3
(es)
|
2013-03-15 |
2018-09-26 |
Intrexon Corporation |
Diacilhidrazinas que contienen boro
|
|
US9719106B2
(en)
|
2013-04-29 |
2017-08-01 |
The Trustees Of The University Of Pennsylvania |
Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
|
|
SG11201609211VA
(en)
*
|
2014-03-05 |
2016-12-29 |
Nat Univ Corp Univ Kobe |
Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same
|
|
WO2016044390A1
(en)
|
2014-09-17 |
2016-03-24 |
Intrexon Corporation |
Boron-containing diacylhydrazine compounds
|
|
US10920215B2
(en)
*
|
2014-11-04 |
2021-02-16 |
National University Corporation Kobe University |
Method for modifying genome sequence to introduce specific mutation to targeted DNA sequence by base-removal reaction, and molecular complex used therein
|
|
EA201792500A1
(ru)
|
2015-05-13 |
2018-04-30 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Aav-опосредованная экспрессия антител против гриппа и способы их использования
|
|
SG11201802912PA
(en)
|
2015-10-10 |
2018-05-30 |
Intrexon Corp |
Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12
|
|
US20180230489A1
(en)
|
2015-10-28 |
2018-08-16 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
|
ES2914623T3
(es)
|
2015-11-27 |
2022-06-14 |
Univ Kobe Nat Univ Corp |
Método para convertir una secuencia genómica de una planta monocotiledónea en la que una base de ácido nucleico en la secuencia de ADN diana se convierte de manera específica y el complejo molecular utilizado en el mismo
|
|
JP7046828B2
(ja)
|
2016-04-15 |
2022-04-04 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
滲出型加齢性黄斑変性の治療のための組成物
|
|
UY37343A
(es)
|
2016-07-25 |
2018-02-28 |
Intrexon Corp |
Control del fenotipo en plantas
|
|
CN110139933B
(zh)
|
2016-11-09 |
2024-03-08 |
英特瑞克斯顿股份有限公司 |
共济蛋白表达构建体
|
|
CA3052487A1
(en)
|
2017-02-28 |
2018-09-07 |
The Trustees Of The University Of Pennsylvania |
Influenza vaccines based on aav vectors
|
|
JP7455579B2
(ja)
|
2017-02-28 |
2024-03-26 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
新規アデノ随伴ウイルス（ａａｖ）クレードｆベクター及びその用途
|
|
JOP20190200A1
(ar)
|
2017-02-28 |
2019-08-27 |
Univ Pennsylvania |
تركيبات نافعة في معالجة ضمور العضل النخاعي
|
|
BR112020007405A2
(pt)
|
2017-10-18 |
2020-12-08 |
Regenxbio Inc. |
Produtos terapêuticos de anticorpo pós-translacionalmente modificados totalmente humanos
|
|
AU2018350990A1
(en)
|
2017-10-18 |
2020-05-21 |
Regenxbio Inc. |
Treatment of ocular diseases and metastatic colon cancer with human post-translationally modified VEGF-Trap
|
|
US12558434B2
(en)
|
2018-02-20 |
2026-02-24 |
The Trustees Of The University Of Pennsylvania |
Compositions for treatment of wet age-related macular degeneration
|
|
EP4667578A3
(en)
|
2019-04-03 |
2026-04-01 |
REGENXBIO Inc. |
Gene therapy for eye pathologies
|
|
KR20220012231A
(ko)
|
2019-04-24 |
2022-02-03 |
리젠엑스바이오 인크. |
완전-인간 번역 후 변형된 항체 치료제
|
|
WO2021041373A1
(en)
|
2019-08-26 |
2021-03-04 |
Regenxbio Inc. |
Treatment of diabetic retinopathy with fully-human post-translationally modified anti-vegf fab
|
|
AU2020362119A1
(en)
|
2019-10-07 |
2022-05-26 |
Regenxbio Inc. |
Adeno-associated virus vector pharmaceutical composition and methods
|
|
WO2022060916A1
(en)
|
2020-09-15 |
2022-03-24 |
Regenxbio Inc. |
Vectorized antibodies for anti-viral therapy
|
|
EP4213890A1
(en)
|
2020-09-15 |
2023-07-26 |
RegenxBio Inc. |
Vectorized lanadelumab and administration thereof
|
|
CA3197342A1
(en)
|
2020-10-07 |
2022-04-14 |
Regenxbio Inc. |
Gene therapy for ocular manifestations of cln2 disease
|
|
CN116528892A
(zh)
|
2020-10-28 |
2023-08-01 |
再生生物股份有限公司 |
用于眼部适应症的载体化抗TNF-α抗体
|
|
WO2022094157A1
(en)
|
2020-10-28 |
2022-05-05 |
Regenxbio Inc. |
Vectorized anti-cgrp and anti-cgrpr antibodies and administration thereof
|
|
US20230390418A1
(en)
|
2020-10-29 |
2023-12-07 |
Regenxbio Inc. |
Vectorized factor xii antibodies and administration thereof
|
|
CN116457373A
(zh)
|
2020-10-29 |
2023-07-18 |
再生生物股份有限公司 |
用于眼部适应症的载体化TNF-α拮抗剂
|
|
TW202237850A
(zh)
|
2020-12-01 |
2022-10-01 |
賓州大學委員會 |
具有組織特異性靶向基序的新穎構成物及含有其之組成物
|
|
AR125406A1
(es)
|
2021-04-23 |
2023-07-12 |
Univ Pennsylvania |
Nuevas composiciones con motivos selectivos para el cerebro y composiciones que las contienen
|
|
EP4409010A1
(en)
|
2021-10-02 |
2024-08-07 |
The Trustees of The University of Pennsylvania |
Novel aav capsids and compositions containing same
|
|
US20250144243A1
(en)
|
2022-01-25 |
2025-05-08 |
The Trustees Of The University Of Pennsylvania |
Aav capsids for improved heart transduction and detargeting of liver
|
|
WO2023201308A1
(en)
|
2022-04-14 |
2023-10-19 |
Regenxbio Inc. |
Gene therapy for treating an ocular disease
|
|
US20250277004A1
(en)
|
2022-04-18 |
2025-09-04 |
Regenxbio Inc. |
Hybrid aav capsids
|
|
US20250288697A1
(en)
|
2022-05-03 |
2025-09-18 |
Regenxbio Inc. |
Vectorized anti-tnf-alpha inhibitors for ocular indications
|
|
EP4518972A2
(en)
|
2022-05-03 |
2025-03-12 |
RegenxBio Inc. |
Vectorized anti-complement antibodies and complement agents and administration thereof
|
|
IL319873A
(en)
|
2022-09-30 |
2025-05-01 |
Regenxbio Inc |
Treatment of eye diseases with recombinant viral vectors containing anti-VEGF FAB
|
|
WO2024130070A2
(en)
|
2022-12-17 |
2024-06-20 |
The Trustees Of The University Of Pennsylvania |
Recombinant aav capsids with cardiac- and skeletal muscle- specific targeting motifs and uses thereof
|
|
KR20250135916A
(ko)
|
2022-12-17 |
2025-09-15 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
심장 및 골격근 특이적 표적화 모티프를 갖는 재조합 aav 돌연변이체 벡터 및 이를 포함하는 조성물
|
|
WO2024238859A1
(en)
|
2023-05-16 |
2024-11-21 |
Regenxbio Inc. |
Vectorized c5 inhibitor agents and administration thereof
|
|
AU2024271004A1
(en)
|
2023-05-16 |
2026-01-15 |
Regenxbio Inc. |
Vectorized anti-complement antibodies and administration thereof
|
|
AR133098A1
(es)
|
2023-06-29 |
2025-08-27 |
Univ Pennsylvania |
Aav mutante con motivos dirigidos al sistema nervioso central y composiciones que lo contienen
|
|
WO2025102034A1
(en)
|
2023-11-10 |
2025-05-15 |
The Trustees Of The University Of Pennsylvania |
Gene therapy for barth syndrome
|
|
WO2025106661A1
(en)
|
2023-11-14 |
2025-05-22 |
The Trustees Of The University Of Pennsylvania |
Compositions with cardiac and skeletal musclespecific targeting motifs and uses thereof
|
|
WO2025217230A1
(en)
|
2024-04-08 |
2025-10-16 |
Regenxbio Inc. |
Vectorized anti-complement antibodies and complement agents and administration thereof
|